Publications by authors named "Lydia-Joi Marshall"

Purpose: We offered a practice facilitation intervention to family physicians in Ontario, Canada, known to have large numbers of patients not yet vaccinated against coronavirus disease 2019 (COVID-19).

Methods: We conducted a multimethod process evaluation embedded within a randomized controlled trial (clinical trial #NCT05099497). We collected descriptive statistics regarding engagement and qualitative interview data from family physicians and practice facilitators, as well as data from facilitator field notes.

View Article and Find Full Text PDF

Introduction: Living donor (LD) kidney transplant (KT) is the best treatment option for many patients with kidney failure as it improves quality of life and survival compared with dialysis and deceased donor KT. Unfortunately, LDKT is underused, especially among groups marginalised by race and ethnicity. African, Caribbean and Black (ACB) patients are 60%-70% less likely to receive LDKT in Canada compared with white patients.

View Article and Find Full Text PDF
Article Synopsis
  • Kidney transplantation (KT) offers better survival and quality of life than dialysis for end-stage kidney disease (ESKD) patients, but Indigenous communities in Canada face significant barriers to access KT and living donor kidney transplantation (LDKT).
  • The research aims to explore the factors contributing to these inequities, analyzing 26 original research articles and gray literature focused on this issue.
  • Key barriers identified include a lack of culturally relevant medical information, systemic mistrust rooted in colonialism, and logistical challenges, which all contribute to the limited access to KT for Indigenous peoples.
View Article and Find Full Text PDF

Background: Kidney transplantation (KT), a treatment option for end-stage kidney disease (ESKD), is associated with longer survival and improved quality of life compared with dialysis. Inequities in access to KT, and specifically, living donor kidney transplantation (LDKT), have been documented in Canada, along various demographic dimensions. In this article, we review existing evidence about inequitable access to KT and LDKT for patients from communities marginalized by race and ethnicity in Canada.

View Article and Find Full Text PDF